Skip to main content

Table 1 Patient characteristics at baseline

From: Resistance training concomitant to radiotherapy of spinal bone metastases – survival and prognostic factors of a randomized trial

 

Intervention group A (n = 30)

Control group B (n = 30)

P-value

n

%

n

%

 

Age (years)

 Mean (SD)

61.3 +/- 10.1

 

64.1 +/- 10.9

 

0.304

Gender

 Male

14

46.7

19

63.3

0.195

 Female

16

53.3

11

36.7

 

Karnofsky-index (median, range)

80 (70–100)

 

80 (70–100)

 

0.114

Primary site

 Lung cancer

12

40.0

8

26.6

0.320

 Breast cancer

5

16.7

6

20.0

0.542

 Prostate cancer

5

16.7

9

30.0

0.156

 Melanoma

1

3.3

1

3.3

1.000

 Renal cancer

1

3.3

2

6.7

0.875

 Other

6

20.0

4

13.4

0.325

Localization metastases

    

0.717

 Thoracic

17

56.7

14

46.7

 

 Lumbar

9

30.0

13

43.3

 

 Thoracic and lumbar

2

6.7

2

6.7

 

 Sacrum

2

6.7

1

3.3

 

Number metastases

    

0.257

 Mean (range)

1.4 (2–4)

 

1.7 (1–5)

  

 Solitary

22

73.3

18

60.0

 

 Multiple

8

26.7

12

40.0

 

Type of metastases

    

0.781

 osteoblast

9

30.0

10

33.3

0.956

 osteolytic

21

70.0

20

66.7

0.935

Distant metastases at baseline

     

 Visceral

12

40.0

5

16.7

0.045

 brain

3

10.0

4

13.4

0.688

 lung

7

23.3

4

13.4

0.320

 tissue

8

26.7

6

20.0

0.542

Pathological fractures

6

20.0

9

30.0

0.371

Hormonotherapy

10

33.3

16

53.3

0.118

Immunotherapy

7

23.3

5

16.7

0.519

Chemotherapy

25

83.3

20

66.7

0.136

Neurological deficit

0

0.0

2

6.7

0.150

Orthopedic corset at baseline

7

23.3

5

16.7

0.519

Radiotherapy dose completed (Gy)

single dose (median, range)

3 (2–4)

 

3 (2–4)

 

1.000

cumulative dose (median, range)

30 (30–40)

 

30 (30–40)

 

1.000